Schmidt P J Investment Management Inc. lessened its stake in The Allstate Co. (NYSE:ALL – Free Report) by 4.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,398 shares of the insurance provider’s stock after selling 150 shares during the quarter. Schmidt P J Investment Management Inc.’s holdings in Allstate were worth $644,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Woodard & Co. Asset Management Group Inc. ADV purchased a new stake in Allstate in the 3rd quarter valued at $231,000. DT Investment Partners LLC boosted its position in shares of Allstate by 4.5% during the 3rd quarter. DT Investment Partners LLC now owns 2,417 shares of the insurance provider’s stock valued at $458,000 after acquiring an additional 105 shares during the last quarter. IFM Investors Pty Ltd grew its holdings in shares of Allstate by 1.4% in the third quarter. IFM Investors Pty Ltd now owns 53,111 shares of the insurance provider’s stock valued at $10,073,000 after purchasing an additional 729 shares during the period. Mason & Associates Inc acquired a new stake in Allstate during the third quarter worth about $872,000. Finally, Global Assets Advisory LLC purchased a new position in Allstate during the third quarter worth about $206,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Insider Buying and Selling at Allstate
In related news, EVP Robert Toohey sold 16,682 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the transaction, the executive vice president now owns 4,873 shares in the company, valued at approximately $877,968.41. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Toohey sold 16,682 shares of the business’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the sale, the executive vice president now owns 4,873 shares of the company’s stock, valued at $877,968.41. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 192,530 shares of company stock valued at $34,967,665. Insiders own 1.80% of the company’s stock.
Allstate Trading Down 0.4 %
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $1.28. The business had revenue of $15.71 billion during the quarter, compared to analysts’ expectations of $14.04 billion. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same quarter last year, the business posted ($4.42) EPS. Sell-side analysts anticipate that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on ALL shares. Roth Mkm restated a “buy” rating and set a $200.00 price target on shares of Allstate in a report on Wednesday, August 14th. UBS Group raised their target price on Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. JPMorgan Chase & Co. upped their price target on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. Barclays initiated coverage on Allstate in a report on Wednesday, September 4th. They set an “underweight” rating and a $175.00 price target for the company. Finally, Morgan Stanley boosted their price objective on shares of Allstate from $202.00 to $215.00 and gave the company an “overweight” rating in a report on Monday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $206.44.
Get Our Latest Research Report on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- How to Capture the Benefits of Dividend Increases
- The Downtrend in UPS Stock Isn’t Over Yet
- How to Invest in Blue Chip Stocks
- Maximize Portfolio Income with These 3 Dividend ETFs
- How to Effectively Use the MarketBeat Ratings Screener
- Talen Energy: A Nuclear Power Stock That Can Keep Winning
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.